For: | Chen JH, Zeng Z, Zhang XX, Zhang Y, Zhang RW, Wang S, Wu CH, Yu M, Liu D, Xi HL, Zhou YX, An YY, Xu XY. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting. World J Gastroenterol 2017; 23(22): 4072-4079 [PMID: PMC5473126 DOI: 10.3748/wjg.v23.i22.4072] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i22/4072.htm |
Number | Citing Articles |
1 |
K. V. Kalashnyk, O. V. Riabokon, O. V. Tsarova, Yu. Yu. Riabokon, H. V. Yalova. ЕФЕКТИВНІСТЬ РІЗНИХ СХЕМ ПРОТИВІРУСНОЇ ТЕРАПІЇ ХВОРИХ НА ХРОНІЧНИЙ ГЕПАТИТ С, ІНФІКОВАНИХ 1-м ГЕНОТИПОМ ВІРУСУ. Інфекційні хвороби 2019; (2): 15 doi: 10.11603/1681-2727.2019.2.10321
|
2 |
Nipun Verma, Shreya Singh, Gitesh Sawatkar, Virendra Singh. Sofosbuvir induced steven Johnson Syndrome in a patient with hepatitis C virus‐related cirrhosis. Hepatology Communications 2018; 2(1): 16 doi: 10.1002/hep4.1126
|
3 |
Tyng‐Yuan Jang, Ching‐I Huang, Ming‐Lun Yeh, Po‐Cheng Liang, Pei‐Chien Tsai, Yi‐Hung Lin, Ming‐Yen Hsieh, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, Wan‐Long Chuang, Ming‐Lung Yu. Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents. Journal of Gastroenterology and Hepatology 2020; 35(3): 473 doi: 10.1111/jgh.14835
|